Chen Wei, Yoshida Soichiro, Yajima Shugo, Fukushima Hiroshi, Sato Hiroyuki, Hirakawa Akihiro, Yamamoto Takanobu, Honda Hiroyuki, Matsuo Tomohiro, Wada Naoki, Masuda Hitoshi, Fujii Yasuhisa. Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study. Urology. 2026.07; ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data. Low Urin Tract Symptoms. 2026.07; 18 (4): e70083. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Bayesian Secondary Reanalysis of Published Aggregate Data on Circulating Tumor DNA for Molecular Residual Disease Detection Across Cancer Types. Ann Clin Biochem. 2026.07; 45632261475618. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial. Int J Urol. 2026.07; 33 (7): e70582. ( PubMed, DOI )

Yonese Ichiro, Koga Fumitaka, Toide Masahiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Fujiwara Motohiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04). Jpn J Clin Oncol. 2026.07; 56 (7): 885-893. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fujii Yasuhisa. Quantifying benefit of adding docetaxel to androgen receptor-axis therapy in metastatic hormone-sensitive prostate cancer with Bayesian analysis. Int Urol Nephrol. 2026.07; 58 (7): 2609-2611. ( PubMed, DOI )

Yasuda Yosuke, Yoshida Soichiro, Ikeda Sadakatsu, Yonese Ichiro, Sano Yuta, Urasaki Tetsuya, Nakamura Yuki, Tanaka Hajime, Ito Masaya, Miura Yuji, Numao Noboru, Matsuoka Yoh, Koga Fumitaka, Yonese Junji, Fujii Yasuhisa. Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer. Jpn J Clin Oncol. 2026.07; 56 (7): 879-884. ( PubMed, DOI )

Yasuda Yosuke, Yoshida Soichiro, Yajima Shugo, Yamaguchi Yoshitomo, Chen Wei, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Suzuki Kotaro, Ishihara Kensaku, Yonese Ichiro, Tamiya Takashi, Izumi Keita, Yamamoto Takanobu, Nakamura Yuki, Uehara Sho, Toide Masahiro, Araki Saori, Kawamura Naoko, Asano Touko, Takazawa Ryoji, Numao Noboru, Fujii Yasuhisa. Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis. Prostate. 2026.06; 86 (8): 911-919. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Fujii Yasuhisa. Beyond Discrimination Metrics: A Bayesian Reinterpretation of S2,3PSA% for Individual Patient Counseling. Eur Urol Open Sci. 2026.06; 88 9-10. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Fukuda Shohei, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Matsuoka Yoh, Kageyama Yukio, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yonese Junji, Nakayama Akinori, Saito Kazutaka, Ito Masaya, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa. Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects. Int J Urol. 2026.06; 33 (6): e70536. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Yajima Shugo, Fujiwara Motohiro, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Fujii Yasuhisa. Bayesian re-analysis of ERA223 and PEACE-3 temporal dynamics and bone protection in radium-223-treated metastatic castration-resistant prostate cancer. Jpn J Clin Oncol. 2026.06; ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Imasato Naoki, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Postoperative Management After Pathological Complete Response to Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer: An Exploratory Reconstructed Individual Patient Data Analysis. Clin Genitourin Cancer. 2026.06; 24 (6): 102603. ( PubMed, DOI )

Kobayashi Masaki, Matsuoka Yoh, Kimura Koichiro, Matsumoto Shunya, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsy. Urol Oncol. 2026.05; 44 (5): 111081. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment on Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma. Int J Urol. 2026.05; 33 (5): e70480. ( PubMed, DOI )

Shimoda Hiroki, Nakamura Yuki, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Fukushima Hiroshi, Fukuda Shohei, Yuma Waseda, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study. Int J Urol. 2026.05; 33 (5): e70486. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Fujii Yasuhisa. From trial results to bedside decisions: a time-resolved view of CheckMate-9ER. Transl Androl Urol. 2026.05; 15 (5): 148. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Masuda Hitoshi, Fujii Yasuhisa. Rethinking survival visualisation: moving beyond Kaplan-Meier curves and hazard ratios in urology. Transl Androl Urol. 2026.05; 15 (5): 188. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Masuda Hitoshi, Fujii Yasuhisa. Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. Transl Androl Urol. 2026.05; 15 (5): 189. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Nakamura Yuki, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Masuda Hitoshi, Fujii Yasuhisa. Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis. Jpn J Clin Oncol. 2026.05; 56 (5): 636-645. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Fukuda Shohei, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Probabilistic multi-criteria decision analysis comparing single-port and multiport robot-assisted radical prostatectomy and partial nephrectomy: A secondary analysis of systematic review data. J Robot Surg. 2026.04; 20 (1): ( PubMed, DOI )

Muta Rie, Fukushima Hiroshi, Tanaka Hajime, Numao Noboru, Nakamura Yuki, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Yoshida Soichiro, Fujii Yasuhisa. Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study). Int J Urol. 2026.04; 33 (4): e70459. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Hirakawa Akihiro, Yasuda Yosuke, Miura Yuji, Fujii Yasuhisa. Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy. Jpn J Clin Oncol. 2026.04; ( PubMed, DOI )

Tanabe Kenji, Yoshida Soichiro, Fujiwara Motohiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Reanalysis of LUNAR progression-free survival using reconstructed individual patient data: time-varying treatment effects. Int Urol Nephrol. 2026.04; ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Fukuda Shohei, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Matsuoka Yoh, Kageyama Yukio, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yonese Junji, Nakayama Akinori, Saito Kazutaka, Ito Masaya, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa. External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinations. Int Urol Nephrol. 2026.04; ( PubMed, DOI )

Hirose Kohei, Yoshida Soichiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer. Jpn J Clin Oncol. 2026.04; ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Yajima Shugo, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fujiwara Motohiro, Arita Yuki, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101. JCO Clin Cancer Inform. 2026.04; 10 (2): e2500307. ( PubMed, DOI )

Chen Wei, Fukuda Shohei, Yoshida Soichiro, Kobayashi Nao, Fukada Kyohei, Fukunishi Munenori, Otani Yuhi, Fukushima Hiroshi, Yasuda Yosuke, Fu Guangqing, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. Human-in-the-loop validation of an artificial intelligence-driven real-time prostatic capsule recognition model for nerve-sparing robot-assisted radical prostatectomy. Surg Endosc. 2026.04; 40 (4): 3501-3509. ( PubMed, DOI )

Hirose Kohei, Yoshida Soichiro, Chen Wei, Yajima Shugo, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer. Jpn J Clin Oncol. 2026.04; 56 (4): 484-488. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Tanabe Kenji, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysis. Urol Oncol. 2026.04; 44 (4): 110990. ( PubMed, DOI )

Sekiguchi Yuta, Mori Makiko, Maruyama Haruka, Nakao Yuki, Kikuchi Hiroaki, Mandai Shintaro, Ando Fumiaki, Susa Koichiro, Mori Takayasu, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa, Shoda Wakana, Takahashi Daiei, Okazaki Rei, Ikeda Kenji, Yamada Tetsuya, Sohara Eisei, Uchida Shinichi, Mori Yutaro. The Pathophysiological Mechanism of Beni-koji Choleste-Help or Puberulic Acid-Induced Kidney Injury. Kidney Int Rep. 2026.04; 11 (4): 103793. ( PubMed, DOI )

Matsumoto Shunya, Yoshida Soichiro, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fujiwara Motohiro, Fukushima Hiroshi, Yasuda Yosuke, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Masuda Hitoshi, Fujii Yasuhisa. A probabilistic multicriteria decision analysis of robot-assisted versus laparoscopic sacrocolpopexy: a secondary analysis of published meta-analytic data. J Robot Surg. 2026.03; 20 (1): ( PubMed, DOI )

Shimoda Hiroki, Fukuda Shohei, Yafuso Daiki, Yamamoto Kouhei, Ishikawa Yudai, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report. IJU Case Rep. 2026.03; 9 (2): e70170. ( PubMed, DOI )

Yajima Shugo, Chen Wei, Hirose Kohei, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa, Yoshida Soichiro. Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysis. Eur Urol Open Sci. 2026.03; 85 60-70. ( PubMed, DOI )

Tanabe Kenji, Yoshida Soichiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup Results. Int J Urol. 2026.02; 33 (2): e70384. ( PubMed, DOI )

Nakao Yuki, Mori Makiko, Sekiguchi Yuta, Morita Iori, Shindoh Ryota, Mandai Shintaro, Fujiki Tamami, Kikuchi Hiroaki, Ando Fumiaki, Susa Koichiro, Mori Takayasu, Suzuki Ayumi, Nashimoto Yuji, Kaji Hirokazu, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa, Sohara Eisei, Uchida Shinichi, Miyake Kensuke, Mori Yutaro. A Human Kidney Tubuloid Model of Repeated Cisplatin-Induced Cellular Senescence and Fibrosis for Drug Screening. Adv Healthc Mater. 2026.02; 15 (7): e01795. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Hirose Kohei, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trial. Jpn J Clin Oncol. 2026.02; 56 (2): 216-220. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Yajima Shugo, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial. Int J Urol. 2026.02; 33 (2): e70376. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Yajima Shugo, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fujiwara Motohiro, Arita Yuki, Yasuda Yosuke, Tanaka Hajime, Morizane Shuichi, Yokoyama Minato, Masuda Hitoshi, Takenaka Atsushi, Fujii Yasuhisa. A multi‑criteria decision analysis comparing robot‑assisted, laparoscopic, and open radical cystectomy using large-scale Japanese nationwide databases. J Robot Surg. 2026.02; 20 (1): 230. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Masuda Hitoshi, Fujii Yasuhisa. Comparison of Perioperative Chemotherapy Regimens for Muscle-Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials. Int J Urol. 2026.02; 33 (2): e70380. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Fujii Yasuhisa. Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison. Cancer Rep (Hoboken). 2026.02; 9 (2): e70496. ( PubMed, DOI )

Fukushima Hiroshi, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Yoshida Soichiro, Fuji Yasuhisa. Bayesian Re-Interpretation of the CheckMate-9ER Final Analysis: Organ-Site and IMDC Risk-Stratified Probabilities of Benefit. Int J Urol. 2026.02; 33 (2): e70379. ( PubMed, DOI )

Fukushima Hiroshi, Yajima Shugo, Chen Wei, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Arita Yuki, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa, Yoshida Soichiro. Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis. Target Oncol. 2026.01; 21 (1): 1-12. ( PubMed, DOI )

Pyrgidis Nikolaos, Schulz Gerald Bastian, Scilipoti Pietro, Pellegrino Francesco, Casuscelli Jozefina, Tzelves Lazaros, Katsimperis Stamatios, Ciavarella Davide, Mir Maria Carmen, Sokolakis Ioannis, Klatte Tobias, Belinchon Alberto Ramos, Velasco Jorge Caño, Fujii Yasuhisa, Tanaka Hajime, Yoshida Soichiro, Matsumoto Shunya, Umari Paolo, Teoh Jeremy Yuen-Chun, Ming Chris Wong Ho, Simone Giuseppe, Mastroianni Riccardo, Mayr Roman, Giudice Francesco Del, Moschini Marco. The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis. Eur Urol Focus. 2026.01; 12 (1): 88-95. ( PubMed, DOI )

Arita Yuki, Edo Hiromi, Yoshida Soichiro. Structured MRI assessment after neoadjuvant therapy for bladder cancer: the emerging roles of NacVI-RADS and multimodal AI. Eur Radiol. 2026.01; 36 (1): 229-231. ( PubMed, DOI )

Yasuda Yosuke, Yoshida Soichiro, Matsubara Daigoro, Takahara Taro, Yoshimura Ryoichi, Fujii Yasuhisa. Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer. Int J Urol. 2026.01; 33 (1): e70253. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Fukushima Hiroshi, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial. Int J Urol. 2026.01; 33 (1): e70256. ( PubMed, DOI )

Tanaka Hiroki, Kobayashi Masaki, Matsumoto Shunya, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Impact of Approach Routes in MRI-Ultrasound Fusion Prostate Biopsy on Post-Biopsy Complications: A Propensity Score-Matched Analysis. Int J Urol. 2026.01; 33 (1): e70275. ( PubMed, DOI )

Ishikawa Yudai, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. Bladder region-specific analysis of the diagnostic performance of oral 5-aminolevulinic acid fluorescence cystoscopy in non-muscle-invasive bladder cancer. Jpn J Clin Oncol. 2026.01; 56 (1): 97-103. ( PubMed, DOI )

Yasuda Yosuke, Yoshida Soichiro, Yajima Shugo, Fukushima Hiroshi, Hirakawa Akihiro, Fujii Yasuhisa. Bayesian Reanalysis of Adjuvant Nivolumab in Japanese Patients With High-Risk Muscle-Invasive Urothelial Carcinoma. Int J Urol. 2026.01; 33 (1): e70305. ( PubMed, DOI )

Soma Takahiko, Tanaka Hajime, Nakamura Yuki, Numao Noboru, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Tanabe Kenji, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Maezawa Yuya, Toide Masahiro, Takazawa Ryoji, Araki Saori, Kitabayashi Ryo, Hirakawa Akihiro, Yoshida Soichiro, Koga Fumitaka, Fujii Yasuhisa. Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study). Int J Urol. 2026.01; 33 (1): e70329. ( PubMed, DOI )

Chen Wei, Yoshida Soichiro, Ikeda Riko, Yoshimura Ryoichi, Fujii Yasuhisa. Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review. Int J Urol. 2026.01; 33 (1): e70324. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fujiwara Motohiro, Yokoyama Minato, Arita Yuki, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. Probabilistic multi-criteria decision analysis comparing robot-assisted and laparoscopic radical nephroureterectomy. J Robot Surg. 2026.01; 20 (1): 162. ( PubMed, DOI )

Tanabe Kenji, Yoshida Soichiro, Chen Wei, Yajima Shugo, Hirakawa Akihiro, Fujii Yasuhisa. Non-Proportional Hazards Analysis of the RADIOSA Trial Using Reconstructed Individual Patient Data. Int J Urol. 2026.01; 33 (1): e70354. ( PubMed, DOI )

Kaneda Ryo, Murakami Masanori, Hirano Akiko, Nakayama Airi, Uchida Satoru, Tsujimoto Kazutaka, Komiya Chikara, Ikeda Kenji, Fujiwara Hiroki, Nagao Toshikage, Yoshida Soichiro, Fujii Yasuhisa, Yamada Tetsuya. A case of immune thrombocytopenia aggravated by therapy for hypercortisolism in adrenocortical carcinoma. Ther Adv Endocrinol Metab. 2026; 17 20420188261419209. ( PubMed, DOI )

Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, Hiroyuki Sato, Akihiro Hirakawa, Yasuhisa Fujii. Restricted mean survival time comparison of olaparib plus abiraterone versus talazoparib plus enzalutamide in first-line metastatic castration-resistant prostate cancer: indirect analyses of propel and talapro-2. Int Urol Nephrol. 2025.12; ( PubMed, DOI )

Margaret F Meagher, Giacomo Musso, Viraj Master, Hajime Tanaka, Umberto Capitanio, Allesandro Larcher, Mai Dabbas, Dattatraya Patil, Wei Chen, Dhruv Puri, Benjamin H Baker, Shamsunnahar Imtiaz, Cesare Saitta, Shohei Fukuda, Masaki Kobayashi, Andrea Salonia, Alberto Briganti, Yasuhisa Fujii, Francesco Montorsi, Ithaar H Derweesh. Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system. Urol Oncol. 2025.12; 43 (12): 706.e1-706.e10. ( PubMed, DOI )

Hiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, Noboru Numao, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii. Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study. Clin Genitourin Cancer. 2025.12; 23 (6): 102426. ( PubMed, DOI )

Wei Chen, Hajime Tanaka, Soichiro Yoshida, Shunya Matsumoto, Masaki Kobayashi, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Yasuhisa Fujii. Comparisons of Pembrolizumab Plus Lenvatinib, Nivolumab Plus Cabozantinib, and Cabozantinib Monotherapy in Advanced Non-Clear Cell Renal Cell Carcinoma Based on Individual Patient Data Reconstruction. Clin Genitourin Cancer. 2025.12; 23 (6): 102458. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Koichiro Kimura, Yuki Arita, Yasuhisa Fujii. Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial. Eur Urol Focus. 2025.12; ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Akihiro Hirakawa, Hiroyuki Sato, Shugo Yajima, Masaki Kobayashi, Motohiro Fujiwara, Hiroshi Fukushima, Yuki Arita, Yuma Waseda, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii. Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial. Jpn J Clin Oncol. 2025.12; ( PubMed, DOI )

Tetsuya Wako, Go Kimura, Yasuhisa Fujii, Takahiro Osawa, Yosuke Uchitomi, Kazunori Honda, Miki Kondo, Ariko Otani, Yoshihide Mitsuda, Nobuo Shinohara. Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan. Cancers (Basel). 2025.12; 17 (24): ( PubMed, DOI )

Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross, Andreas Røder, Andrea Juliana Gomes, Stephane Supiot, Philippe Barthélémy, Koji Hatano, Carmen Belen Congregado Ruiz, Soichiro Yoshida, Bernardo Herrera-Imbroda, Matthieu Gratton, Jürgen E Gschwend, Thomas A Hope, Heikki Joensuu, Iris Kuss, Marie-Aude Le Berre, Miryana Dimova-Dobreva, Karim Fizazi. Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP). Future Oncol. 2025.11; 21 (27): 3491-3498. ( PubMed, DOI )

Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh. Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025.11; 205 99-107. ( PubMed, DOI )

Soichiro Yoshida, Yosuke Yasuda, Yasuhisa Fujii. Editorial Comment to "Effects of Modifying Hinotori Surgical Robot System on the Surgical Step of the Dissection of the Renal Hilum and the Kidney Isolation". Int J Urol. 2025.11; 32 (11): 1707-1708. ( PubMed, DOI )

Yosuke Yasuda, Zijie Wang, Soichiro Yoshida, Wei Chen, Hajime Tanaka, Yasuhisa Fujii. Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer. Int J Urol. 2025.11; 32 (11): 1709-1711. ( PubMed, DOI )

Cesare Saitta, Giacomo Musso, Giuseppe Garofano, Hajime Tanaka, Dattatraya Patil, Margaret F Meagher, Srinivas Vourganti, Edward Cherullo, Michael Liss, Marco Paciotti, Giovanni Lughezzani, Nicolò M Buffi, Viraj Master, Yasuhisa Fujii, Rana R McKay, Ithaar H Derweesh. Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers (Basel). 2025.10; 17 (21): ( PubMed, DOI )

Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study). Int J Urol. 2025.10; 32 (10): 1369-1378. ( PubMed, DOI )

Yosuke Yasuda, Noboru Numao, Shunya Matsumoto, Takashi Tamiya, Yuki Nakamura, Hajime Tanaka, Soichiro Yoshida, Shuichiro Kobayashi, Ryoji Takazawa, Yoh Matsuoka, Junji Yonese, Yasuhisa Fujii. Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study. Int J Urol. 2025.10; 32 (10): 1413-1418. ( PubMed, DOI )

Shunya Matsumoto, Yuma Waseda, Masaki Kobayashi, Yuki Nakamura, Yudai Ishikawa, Hiroshi Fukushima, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing Surgery. Anticancer Res. 2025.10; 45 (10): 4333-4341. ( PubMed, DOI )

Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, Mattia Longoni, Alfonso Santangelo, José Daniel Subiela, Roberto Contieri, Luca Afferi, Stefania Zamboni, Nazareno Suardi, Gennaro Musi, Stefano Luzzago, David D'Andrea, Ekaterina Laukhtina, Francesco Soria, Paolo Gontero, Francesco Del Giudice, Muhammad Shamim Khan, Ramesh Thurairaja, Morgan Roupret, Elisabeth Grobet-Jeandin, Arthur Baudewyns, Hajime Tanaka, Shunya Matsumoto, Yasuhisa Fujii, Flavia Proietti, Giuseppe Simone, Gerald Bastian Schulz, Nicolaos Pyrgidis, Guillaume Ploussard, Alessandro Antonelli, Riccardo Bertolo, Mathieu Roumiguie, Anne-Sophie Bajeot, Maria Carme Mir, Paolo Umari, Jeremy Teoh, Chris Wong, Laura S Mertens, Renate Pichler, Keiichiro Mori, Aleksander Ślusarczyk, Cédric Poyet, Simone Albisinni, Atiqullah Aziz, Alessandro Volpe, Shahrokh Shariat, Benjamin Pradere, Pierre Karakiewicz, Stefano Resca, Edoardo Beatrici, Ruben De Groote, Alexandre Mottrie, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Marco Moschini, . Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study. World J Urol. 2025.10; 43 (1): 636. ( PubMed, DOI )

Nonaka Daichi, Yoshida Soichiro, Nakano Kenta, Li Xiaojun, Okamura Tadashi, Umemoto Eiji, Yamada Taisho, Watanabe Miyuki, Jinno Shozo, Ito Minako, Tsuda Makoto, Noguchi Naoto, Jiang Jean X, Sumiya Eriko, Sawa Shinichiro. Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection. Mucosal Immunol. 2025.10; 18 (5): 1113-1123. ( PubMed, DOI )

Giacomo Musso, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Omer Baker, Aaron Ahdoot, Dhruv Puri, Mai Dabbas, Natalie Birouty, Cesare Saitta, Melis Guer, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Andrea Salonia, Umberto Capitanio, Alessandro Larcher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinoma. Urol Oncol. 2025.08; 43 (8): 470.e1-470.e9. ( PubMed, DOI )

Tsuji Takumasa, Yoshida Soichiro, Hommyo Mitsuki, Oyama Asuka, Kumagai Shinobu, Shiraishi Kenshiro, Kotoku Jun'ichi. Cone Beam Computed Tomography Image-Quality Improvement Using "One-Shot" Super-resolution. J Imaging Inform Med. 2025.08; 38 (4): 2120-2133. ( PubMed, DOI )

Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii. Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study). Int J Clin Oncol. 2025.06; 30 (6): 1237-1246. ( PubMed, DOI )

Cesare Saitta, Riccardo Autorino, Umberto Capitanio, Giovanni Lughezzani, Margaret F Meagher, Kendrick Yim, Mimi V Nguyen, Matilde Mantovani, Melis Guer, Daniele Amparore, Federico Piramide, Kevin Hakimi, Dattatraya Patil, Hajime Tanaka, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Savio D Pandolfo, Julian Cortes, Dhruv Puri, Kit Yuen, Massimo Lazzeri, Vittorio Fasulo, Alessandro Larcher, Marco Paciotti, Giuseppe Garofano, Francesco Porpiglia, Francesco Montorsi, Yasuhisa Fujii, Viraj Master, Nicolò M Buffi, Ithaar H Derweesh. Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102343. ( PubMed, DOI )

Cesare Saitta, Giuseppe Garofano, Giacomo Musso, Hajime Tanaka, Dattatraya Patil, Vi Nguyen, Kit L Yuen, Benjamin Baker, Mai Dabbas, Margaret F Meagher, Dhruv Puri, Natalie Birouty, Omer Baker, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Giovanni Lughezzani, Alessandro Larcher, Umberto Capitanio, Riccardo Melloni, Mario Catanzaro, Sebastiano Nazzani, Nicola Nicolai, Yasuhisa Fujii, Viraj Master, Nicolòmaria Buffi, Ithaar H Derweesh. UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion. World J Urol. 2025.06; 43 (1): 355. ( PubMed, DOI )

Wei Chen, Shohei Fukuda, Soichiro Yoshida, Nao Kobayashi, Kyohei Fukada, Munenori Fukunishi, Yuhi Otani, Shunya Matsumoto, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Hiroshi Fukushima, Guangqing Fu, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Pioneering AI-guided fluorescence-like navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network. J Robot Surg. 2025.04; 19 (1): 188. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol. 2025.04; 32 (4): 361-370. ( PubMed, DOI )

Wei Chen, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Akinori Nakayama, Margaret F Meagher, Soichiro Yoshida, Ithaar H Derweesh, Viraj A Master, Akihiro Hirakawa, Yasuhisa Fujii, Kazutaka Saito. Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study. Int J Urol. 2025.04; 32 (4): 414-422. ( PubMed, DOI )

Yuma Waseda, Wei Chen, Minato Yokoyama, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Masumi Ai, Akihiro Hirakawa, Kiyohide Fushimi, Yasuhisa Fujii. Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysis. Int J Urol. 2025.04; 32 (4): 409-413. ( PubMed, DOI )

Rikuto Yasujima, Hajime Tanaka, Junichi Tsuchiya, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii. F-fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma. Int J Urol. 2025.04; 32 (4): 453-455. ( PubMed, DOI )

Yuki Nakamura, Hajime Tanaka, Noboru Numao, Masaharu Inoue, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Masahiro Toide, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii. Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study). Clin Genitourin Cancer. 2025.04; 23 (2): 102301. ( PubMed, DOI )

Patrizia Giannatempo, Jean-Pascal Machiels, Naoto Sassa, Jose Angel Arranz, Yasuhisa Fujii, Wen-Pin Su, Bhumsuk Keam, Stéphane Culine, Ying-Chun Shen, José Muñoz Langa, David Sarid, Maureen Aarts, Fabio Calabrò, Eli Rosenbaum, Blanca Homet Moreno, Abhishek Bavle, Jin Z Xu, Sun Young Rha. Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials. Clin Genitourin Cancer. 2025.04; 23 (2): 102273. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Yasuhisa Fujii. Is Docetaxel Essential for Darolutamide-Based Metastatic Hormone-Sensitive Prostate Cancer Therapy? Int J Urol. 2025.04; ( PubMed, DOI )

Naohiro Yamaya, Koichiro Kimura, Ryota Ichikawa, Masaaki Kawanishi, Yusuke Kawasaki, Subaru Higuchi, Kenichi Fukui, Junichi Tsuchiya, Masaki Kobayashi, Soichiro Yoshida, Yasuhisa Fujii, Ukihide Tateishi. Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy. Jpn J Radiol. 2025.03; 43 (3): 472-482. ( PubMed, DOI )

Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii. The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2025.03; 32 (3): 264-269. ( PubMed, DOI )

Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi. Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2025.03; 116 (3): 572-580. ( PubMed, DOI )

Takanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, Takashi Tamiya, Masahiro Toide, Hiroshi Fukushima, Sho Uehara, Saori Araki, Masaya Ito, Shuichiro Kobayashi, Atsushi Yoshinaga, Naoko Kawamura, Ryoji Takazawa, Yasuyuki Sakai, Yukihiro Ootsuka, Tetsuro Tsukamoto, Katsushi Nagahama, Hajime Tanaka, Ryo Kitabayashi, Ryoichi Hanazawa, Megumi Ishiguro, Hiroyuki Sato, Ryuji Koike, Yasuhisa Fujii. Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol BMJ Open. 2025.03; 15 (3): e094230. ( PubMed, DOI )

Kohei Isemoto, Yuma Waseda, Motohiro Fujiwara, Koichiro Kimura, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Yuki Arita, Thomas C Kwee, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics (Basel). 2025.03; 15 (7): ( PubMed, DOI )

Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi. Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2025.03; 116 (3): 572-580.

Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii. The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2025.03; 32 (3): 264-269.

Matsumoto Shunya, Ishikawa Yudai, Fukushima Hiroshi, Yamamoto Kouhei, Tsujimoto Kazutaka, Kimura Koichiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor. IJU Case Rep. 2025.03; 8 (2): 93-96. ( PubMed, DOI )

Toshinari Horie, Motohiro Fujiwara, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. Int J Urol. 2025.01; 32 (1): 121-123. ( PubMed, DOI )

Yuki Arita, Thomas C Kwee, Oguz Akin, Keisuke Shigeta, Ramesh Paudyal, Christian Roest, Ryo Ueda, Alfonso Lema-Dopico, Sunny Nalavenkata, Lisa Ruby, Noam Nissan, Hiromi Edo, Soichiro Yoshida, Amita Shukla-Dave, Lawrence H Schwartz. Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer. Insights Imaging. 2025.01; 16 (1): 7. ( PubMed, DOI )

Wei Chen, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Akinori Nakayama, Margaret F Meagher, Rachel Greenwald, Benjamin Schmeusser, Edouard Nicase, Yuma Waseda, Soichiro Yoshida, Ithaar H Derweesh, Viraj A Master, Yasuhisa Fujii, Kazutaka Saito. Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World J Urol. 2025.01; 43 (1): 63. ( PubMed, DOI )

Makiko Mori, Yutaro Mori, Yuki Nakao, Shintaro Mandai, Tamami Fujiki, Hiroaki Kikuchi, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii, Eisei Sohara, Shinichi Uchida. Development of Adult Renal Tubular Organoids from Different Human Individuals in a Single Medium. JMA J. 2025.01; 8 (1): 191-197. ( PubMed, DOI )

Kazunari Hara, Masanori Murakami, Kumiko Shiba, Kazutaka Tsujimoto, Chikara Komiya, Kenji Ikeda, Kurara Yamamoto, Towako Taguchi, Takumi Akashi, Soichiro Yoshida, Kenichi Ohashi, Yasuhisa Fujii, Tetsuya Yamada. Unexpected Remission of Bilateral Hyperaldosteronism After Unilateral Cortisol-Producing Adenoma Resection: A Report of Two Cases. Case Rep Endocrinol. 2025; 2025 9941688. ( PubMed, DOI )

Koichiro Kimura, Tatsuya Yamamoto, Junichi Tsuchiya, Soichiro Yoshida, Shuichi Yanai, Iichiro Onishi, Yasuhisa Fujii, Ukihide Tateishi. A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview. Abdom Radiol (NY). 2024.12; 49 (12): 4416-4436. ( PubMed, DOI )

Kotaro Shimada, Motohiro Fujiwara, Daisuke Hirahara, Eichi Takaya, Soichiro Yoshida, Yasuhisa Fujii. Monitoring prostate cancer after low-dose-rate hemigland brachytherapy with delta-radiomics of diffusion-weighted magnetic resonance imaging. Int J Urol. 2024.12; 31 (12): 1443-1445. ( PubMed, DOI )

Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed, DOI )

Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma. Mod Pathol. 2024.11; 37 (11): 100590. ( PubMed, DOI )

Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed, DOI )

Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed, DOI )

Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed, DOI )

Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, Sadakatsu Ikeda, Junko Kunieda, Kenichi Ohashi, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab IJU Case Rep. 2024.09; 7 (5): 395-398. ( PubMed, DOI )

Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU Case Rep. 2024.07; 7 (4): 293-296. ( PubMed, DOI )

Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii. Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed, DOI )

Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. Int J Urol. 2024.07; 31 (7): 739-746. ( PubMed, DOI )

Shintaro Asai, Masaki Kobayashi, Shohei Fukuda, Koichiro Kimura, Soichiro Yoshida, Yasuhisa Fujii. Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis. Int J Urol. 2024.06; 31 (6): 693-695. ( PubMed, DOI )

Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1.

Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1. ( PubMed, DOI )

Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291.

Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291. ( PubMed, DOI )

Yudai Ishikawa, Hajime Tanaka, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. Int J Urol. 2024.03; 31 (3): 238-244. ( PubMed, DOI )

Bo Fan, Minato Yokoyama, Masaki Kobayashi, Yuki Nakamura, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. Int J Urol. 2024.02; 31 (2): 119-124. ( PubMed, DOI )

Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

Matsuoka Yoh, Ueno Yoshihiko, Uehara Sho, Tanaka Hiroshi, Kobayashi Masaki, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Kumazawa Itsuo, Fujii Yasuhisa. Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. Int J Urol. 2023.12; 30 (12): 1103-1111. ( PubMed, DOI )

Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. Int J Urol. 2023.11; 30 (11): 1014-1019. ( PubMed, DOI )

Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. Int J Urol. 2023.11; 30 (11): 1056-1058. ( PubMed, DOI )

Yamaguchi Yoshitomo, Tanaka Hajime, Kimura Koichiro, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Hirakawa Akihiro, Tateishi Ukihide, Campbell Steven C, Fujii Yasuhisa. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. Int J Urol. 2023.10; 30 (10): 913-921. ( PubMed, DOI )

Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Kitazume Yoshio, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Toda Kazuma, Yoshimura Ryoichi, Masaya Ito, Koga Fumitaka, Tateishi Ukihide, Fujii Yasuhisa. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. Eur Radiol. 2023.09; 33 (9): 6245-6255. ( PubMed, DOI )

Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU Case Rep. 2023.07; 6 (4): 216-218. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer. Int J Urol. 2023.07; 30 (7): 616-617. ( PubMed, DOI )

Mizuno Yuki, Yoshida Soichiro, Okamoto Kentaro, Fujii Yasuhisa. Utility of an endoscopic image processing system for framing laparoscopic images using surgeon's gaze point and voice commands during laparoscopic percutaneous extraperitoneal closure of inguinal hernia in children. Wideochir Inne Tech Maloinwazyjne. 2023.06; 18 (2): 372-377. ( PubMed, DOI )

Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. Int J Urol. 2023.06; 30 (6): 532-538. ( PubMed, DOI )

Uchida Yusuke, Yokoyama Minato, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujiwara Takeo, Fujii Yasuhisa. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer. Urol Res Pract. 2023.05; 49 (3): 162-168. ( PubMed, DOI )

Fujiwara Motohiro, Yoshida Soichiro, Takahara Taro, Soma Takahiko, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer. Clin Exp Metastasis. 2023.04; 40 (2): 187-195. ( PubMed, DOI )

Kijima Toshiki, Fukuda Shohei, Fukushima Hiroshi, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma. Jpn J Clin Oncol. 2023.04; 53 (5): 436-442. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Ito Masaya, Hayakawa Sara, Oguchi Tomohiko, Komai Yoshinobu, Numao Noboru, Yuasa Takeshi, Inoue Masaharu, Ushijima Hiroki, Kudo Shigehiro, Shimano Yasumasa, Nakamura Yuki, Uchida Yusuke, Uehara Sho, Tanaka Hajime, Yaegashi Hiroshi, Izumi Kouji, Yokoyama Minato, Matsuoka Yoh, Yoshioka Yasuo, Konishi Koji, Nakanishi Katsuyuki, Nagahara Akira, Hirakawa Akihiro, Koike Ryuji, Koga Fumitaka, Nishimura Kazuo, Mizokami Atsushi, Yonese Junji, Kageyama Yukio, Yoshimura Ryoichi, Fujii Yasuhisa. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC Urol. 2023.03; 23 (1): 33. ( PubMed, DOI )

Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study. Int J Urol. 2023.03; 30 (3): 258-263. ( PubMed, DOI )

Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Jpn J Clin Oncol. 2023.03; 53 (3): 263-269. ( PubMed, DOI )

Tanaka Hajime, Fukuda Shohei, Kimura Koichiro, Fukawa Yuki, Yamamoto Kouhei, Fukushima Hiroshi, Moriyama Shingo, Yasuda Yosuke, Uehara Sho, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Tateishi Ukihide, Campbell Steven C, Fujii Yasuhisa. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed, DOI )

Arita Yuki, Yoshida Soichiro, Shigeta Keisuke, Kwee Thomas C, Edo Hiromi, Okawara Naoko, Hashimoto Masahiro, Ishii Ryota, Ueda Ryo, Mikami Shuji, Fujiwara Motohiro, Waseda Yuma, Kikuchi Eiji, Fujii Yasuhisa, Jinzaki Masahiro. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol. 2023.02; 6 (1): 99-102. ( PubMed, DOI )

Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed, DOI )

Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii YJinzaki M. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology Eur Urol Oncol . 2022.08; ( DOI )

Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol . 2022.08; 18 (4): 410-418.

Yamamoto Shumpei, Fukushima Hiroshi, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol. 2022.08; 18 (4): 410-418. ( PubMed, DOI )

Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) . 2022.06; 47 (6): 2178-2186.

Matsumoto Shunya, Arita Yuki, Yoshida Soichiro, Fukushima Hiroshi, Kimura Koichiro, Yamada Ichiro, Tanaka Hajime, Yagi Fumiko, Yokoyama Minato, Matsuoka Yoh, Oya Mototsugu, Tateishi Ukihide, Jinzaki Masahiro, Fujii Yasuhisa. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdom Radiol (NY). 2022.06; 47 (6): 2178-2186. ( PubMed, DOI )

Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol . 2022.04; 40 (4): 161.

Matsuoka Yoh, Uehara Sho, Toda Kazuma, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urol Oncol. 2022.04; 40 (4): 161.e15-161.e23. ( PubMed, DOI )

Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hiromi Edo, Ryohei Kufukihara, Keisuke Shigeta, Misa Nagasaka, Ryo Takeshita, Haruka Okamura, Ryo Ueda, Ryota Ishii, Shigeo Okuda, Yasuhisa Fujii. Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. Eur J Radiol. 2022.03; 148 110163. ( PubMed, DOI )

Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel) (IF: 5.25; Q2). 2022.03;

Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity World J Urol . 2022.03; 40 (3): 871-873.

Yoshida S, Fujii Y. Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis Int J Urol . 2022.03; 29 (3): 196.

Uchida Yusuke, Yoshida Soichiro, Arita Yuki, Shimoda Hiroki, Kimura Koichiro, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Jinzaki Masahiro, Fujii Yasuhisa. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel). 2022.03; 12 (4): ( PubMed, DOI )

Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis. Int J Urol. 2022.03; 29 (3): 196. ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01; 14 (3): 567.

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol . 2022.01; 32 (1): 671-679.

Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers (Basel). 2022.01; 14 (3): ( PubMed, DOI )

Yuki Arita, Hirotaka Akita, Hirokazu Fujiwara, Masahiro Hashimoto, Keisuke Shigeta, Thomas C Kwee, Soichiro Yoshida, Takeo Kosaka, Shigeo Okuda, Mototsugu Oya, Masahiro Jinzaki. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements. Eur J Radiol Open. 2022; 9 100403. ( PubMed, DOI )

Tanaka H*, Fukuda S, Kimura K, Fukawa Y, Yamamoto K, Fukushima H, Moriyama S, Yasuda Y, Uehara S, Waseda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Tateishi U, Campbell SC, Fujii Y. . Defining tumour shape irregularity for preoperative risk stratification of clinically localised renal cell carcinoma Eur Urol Open Sci. . 2022;

Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

Ishikawa Yudai, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Sakai Yasuyuki, Otsuka Yukihiro, Takazawa Ryoji, Yano Masataka, Tsukamoto Tetsuro, Okuno Tetsuo, Noro Akira, Nagahama Katsushi, Kamata Shigeyoshi, Fujii Yasuhisa. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel). 2021.12; 11 (12): ( PubMed, DOI )

Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C, Fujii Yasuhisa. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. Int J Urol. 2021.12; 28 (12): 1233-1239. ( PubMed, DOI )

Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. Int J Urol. 2021.12; 28 (12): 1268-1272. ( PubMed, DOI )

Yoshida Soichiro, Fujii Yasuhisa. MRI-Targeted Biopsy in Prostate Cancer Screening. N Engl J Med. 2021.11; 385 (22): 2110. ( PubMed, DOI )

Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki. Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed, DOI )

Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.08; 54 (2): 401-408. ( PubMed, DOI )

Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, . Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed, DOI )

Kobayashi Masaki, Ishioka Junichiro, Matsuoka Yoh, Fukuda Yuichi, Kohno Yusuke, Kawano Keizo, Morimoto Shinji, Muta Rie, Fujiwara Motohiro, Kawamura Naoko, Okuno Tetsuo, Yoshida Soichiro, Yokoyama Minato, Suda Rumi, Saiki Ryota, Suzuki Kenji, Kumazawa Itsuo, Fujii Yasuhisa. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray. BMC Urol. 2021.08; 21 (1): 102. ( PubMed, DOI )

Yoshida S, Fujii Y. Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2021.07; 28 (7): 756. ( PubMed, DOI )

Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.07; ( PubMed, DOI )

Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

Saito K, Matsuoka Y, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.07; 20 (4): 842-848. ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Toda K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. International urology and nephrology. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2021.06; ( PubMed, DOI )

Yamazaki A, Ito T, Sugimoto M, Yoshida S, Honda K, Kawashima Y, Fujikawa T, Fujii Y, Tsutsumi T. Patient-specific virtual and mixed reality for immersive, experiential anatomy education and for surgical planning in temporal bone surgery. Auris, nasus, larynx. 2021.05; ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y. Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. International journal of urology : official journal of the Japanese Urological Association. 2021.05; 28 (5): 502-513. ( PubMed, DOI )

Arita Y, Yoshida S, Waseda Y, Takahara T, Ishii C, Ueda R, Kwee TC, Miyahira K, Ishii R, Okuda S, Jinzaki M, Fujii Y. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. European journal of radiology. 2021.04; 137 109581. ( PubMed, DOI )

Yoshida S, Fujii Y. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports. 2021.03; 4 (2): 73-74. ( PubMed, DOI )

Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer(和訳中) IJU Case Reports. 2021.03; 4 (2): 73-74. ( ichushi )

Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique(和訳中) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?(和訳中) International Journal of Urology. 2021.02; 28 (2): 241-242. ( ichushi )

Fukuda S, Saito K, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kageyama Y, Fujii Y. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer. 2021.02; 9 (2): ( PubMed, DOI )

Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World journal of urology. 2021.01; ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems(和訳中) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

Fukushima H, Yoshida S, Kijima T, Nakamura Y, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. International journal of molecular sciences. 2021.01; 22 (2): ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems. Int J Urol. 2021.01; 28 (1): 127-129. ( PubMed, DOI )

Waseda Y, Yoshida S, Arita Y, Takahara T, Sakamoto T, Saito K, Fujii Y. Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy. Urologia internationalis. 2021; 105 (5-6): 507-513. ( PubMed, DOI )

Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. International journal of urology : official journal of the Japanese Urological Association. 2020.12; ( PubMed, DOI )

Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International journal of urology : official journal of the Japanese Urological Association. 2020.11; ( PubMed, DOI )

Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer medicine. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer immunology, immunotherapy : CII. 2020.09; ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anti-cancer drugs. 2020.09; 31 (8): 866-871. ( PubMed, DOI )

Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 634-635. ( PubMed, DOI )

Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 599-604. ( PubMed, DOI )

Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa. Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy (vol 27, pg 471, 2020) INTERNATIONAL JOURNAL OF UROLOGY. 2020.07; 27 (7): 636. ( DOI )

Kaneko Kasumi, Yoshida Soichiro, Yamamoto Kouhei, Arita Yuki, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging(和訳中) International Journal of Urology. 2020.07; 27 (7): 599-604. ( ichushi )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yoshimura Ryoichi, Fujii Yasuhisa. Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer(和訳中) International Journal of Urology. 2020.07; 27 (7): 634-635. ( ichushi )

Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clinical genitourinary cancer. 2020.07; ( PubMed, DOI )

Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. International journal of urology : official journal of the Japanese Urological Association. 2020.06; ( PubMed, DOI )

Nakamura Yuki, Yokoyama Minato, Yoshida Soichiro, Tanaka Hajime, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Minami Isao, Yoshimoto Takanobu, Naito Shotaro, Ogawa Yoshihiro, Yamada Tetsuya, Uchida Shinichi, Fujii Yasuhisa. クッシング症候群患者における副腎摘除後の術後腎機能障害と長期にわたる腎機能変化(Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome) International Journal of Urology. 2020.05; 27 (5): 395-400. ( ichushi )

Yoshida Soichiro, Taniguchi Naoji, Moriyama Shingo, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. MRI撮影-超音波検査融合画像による前立腺生検の患者説明におけるバーチャルリアリティの応用(Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy) International Journal of Urology. 2020.05; 27 (5): 471-472. ( ichushi )

Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Lower urinary tract symptoms. 2020.04; ( PubMed, DOI )

Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.03; 27 (3): 236-243. ( PubMed, DOI )

Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. Clinical genitourinary cancer. 2020.02; ( PubMed, DOI )

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. . Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol. 2020; 27: 634-635. doi: 10.1111/iju.14249.. 2020;

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

SoichiroYoshida1TaroTakahara23ChikakoIshii3YukiArita34YumaWaseda1ToshikiKijima1MinatoYokoyama1JunichiroIshioka1YohMatsuoka1KazutakaSaito1YasuhisaFujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int J Urol. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

Kijima Toshiki, Tanaka Hajime, Koga Fumitaka, Masuda Hitoshi, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

Yajima Shugo, Yoshida Soichiro, Takahara Taro, Arita Yuki, Tanaka Hiroshi, Waseda Yuma, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol. 2019.07; 29 (7): 3881-3888. ( PubMed, DOI )

Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment to Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management. Int J Urol. 2019.07; ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Ishii Chikako, Uchida Yusuke, Nakagawa Keiko, Toda Kazuma, Sakamoto Tsuyoshi, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. Int J Radiat Oncol Biol Phys. 2019.06; ( PubMed, DOI )

Yoshida Soichiro, Maeda Takeshi, Yokoyama Minato, Toide Masahiro, Saito Kazutaka, Fujii Yasuhisa. Application of eye tracking as a user interface for urological surgery. Int J Urol. 2019.06; 26 (6): 680-681. ( PubMed, DOI )

Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa. Mixed reality computed tomography-based surgical planning for partial nephrectomy using a head-mounted holographic computer. Int J Urol. 2019.06; 26 (6): 681-682. ( PubMed, DOI )

Arita Yuki, Takahara Taro, Yoshida Soichiro, Kwee Thomas C, Yajima Shugo, Ishii Chikako, Ishii Ryota, Okuda Shigeo, Jinzaki Masahiro, Fujii Yasuhisa. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.05; ( PubMed, DOI )

Kijima Toshiki, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2019.03; 37 (7):

Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa. Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. Int J Urol. 2019.02; 26 (2): 273-277. ( PubMed, DOI )

Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa. 褐色細胞腫切除後の低血糖の発生率と予測因子(Incidence and predictive factors of hypoglycemia after pheochromocytoma resection) International Journal of Urology. 2019.02; 26 (2): 273-277. ( ichushi )

Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

Yoshida Soichiro, Fujii Yasuhisa. High cell proliferation as a predictive factor for favorable response to chemoradiotherapy against bladder cancer CANCER SCIENCE. 2018.12; 109 1220.

Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Clinical genitourinary cancer. 2018.12; 16 (6): e1151-e1158. ( PubMed, DOI )

Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed, DOI )

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Fujii Yasuhisa. MRI/ultrasound elastic fusion prostate biopsy : application to lesion - specific treatment of local therapy INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 167.

Yoshida Soichiro, Takahara Taro, Ishii Chikako, Nakagawa Keiko, Toda Kazuma, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa. Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 358.

Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association. 2018.09; ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 2018.06; ( PubMed, DOI )

Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. T2強調MRIにおける小径腎腫瘍の信号強度比曲線解析　脂肪成分の少ない腎血管筋脂肪腫と腎細胞癌との鑑別(Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed, DOI )

Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. international journal of urology. 2018.03; ( PubMed, DOI )

Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2018.02; 36 (6):

Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. urologia internationalis. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. Journal of magnetic resonance imaging : JMRI. 2017.08; 46 (2): 490-496. ( PubMed, DOI )

Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR. American journal of roentgenology. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

Soichiro Yoshida, Tsuneo Fukuyo, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery. International journal of urology : official journal of the Japanese Urological Association. 2017.08; 24 (8): 639-640. ( PubMed, DOI )

Yoshida Soichiro, Fukuyo Tsuneo, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 単孔式腹腔鏡下手術における手-目協調の改善のためのリアルタイム三次元画像の角度調整(Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery) International Journal of Urology. 2017.08; 24 (8): 639-640. ( ichushi )

Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clinical imaging. 2017.07; 44 121-126. ( PubMed, DOI )

Soichiro Yoshida, Taro Takahara, Thomas C Kwee, Yuma Waseda, Shuichiro Kobayashi, Yasuhisa Fujii. DWI as an Imaging Biomarker for Bladder Cancer. AJR. American journal of roentgenology. 2017.06; 208 (6): 1218-1228. ( PubMed, DOI )

Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urologia internationalis. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A novel interactive educational system in the operating room--the IE system. BMC medical education. 2016.02; 16 44. ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urologia internationalis. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

Kenji Tanabe, Soichiro Yoshida, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clinical genitourinary cancer. 2015.08; 13 (4): e243-e251. ( PubMed, DOI )

Soichiro Yoshida, Asami Sasaki, Chikage Sato, Mutsuko Yamazaki, Junya Takayasu, Naofumi Tanaka, Norie Okabayashi, Hiromi Hirano, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A Novel Approach to Surgical Instructions for Scrub Nurses by Using See-Through-Type Head-Mounted Display. Comput Inform Nurs. 2015.08; 33 (8): 335-338. ( PubMed, DOI )

Soichiro Yoshida, Kazunori Kihara, Tsuneo Fukuyo, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii. Novel three-dimensional image system for transurethral surgery. Int. J. Urol.. 2015.07; 22 (7): 714-715. ( PubMed, DOI )

Soichiro Yoshida, Naotaka Fukui, Kazutaka Saito, Yasuhisa Fujii, Yukio Kageyama, Kazunori Kihara. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. Int. J. Urol.. 2015.05; 22 (5): 520-521. ( PubMed, DOI )

Junichiro Ishioka, Kazutaka Saito, Toshiki Kijima, Yasukazu Nakanishi, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Hitoshi Masuda, Yasuhisa Fujii, Yasuyuki Sakai, Chizuru Arisawa, Tetsuo Okuno, Katsuhi Nagahama, Shigeyoshi Kamata, Mizuaki Sakura, Junji Yonese, Shinji Morimoto, Akira Noro, Toshihiko Tsujii, Satoshi Kitahara, Shuichi Gotoh, Yotsuo Higashi, Kazunori Kihara. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU international. 2015.05; 115 (5): 705-712. ( PubMed, DOI )

Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urologia internationalis. 2015.04; ( PubMed, DOI )

Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

Hideki Takeshita, Satoru Kawakami, Noboru Numao, Mizuaki Sakura, Manabu Tatokoro, Shinya Yamamoto, Toshiki Kijima, Yoshinobu Komai, Kazutaka Saito, Fumitaka Koga, Yasuhisa Fujii, Iwao Fukui, Kazunori Kihara. Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU international. 2015.03; 115 (3): 412-418. ( PubMed, DOI )

Soichiro Yoshida, Kazunori Kihara, Hideki Takeshita, Yasukazu Nakanishi, Toshiki Kijima, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Head-mounted display for a personal integrated image monitoring system: ureteral stent placement. Urologia internationalis. 2015.01; 94 (1): 117-120. ( PubMed, DOI )

Masaharu Inoue, Kazunori Kihara, Soichiro Yoshida, Masaya Ito, Hideki Takeshita, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2015.01; 34 (1): 29-35. ( PubMed, DOI )

Manabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, Kazunori Kihara. Heat shock protein 90 targeting therapy: state of the art and future perspective. EXCLI journal. 2015; 14 48-58. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2014.12; 21 (12): 1190-1200. ( PubMed, DOI )

Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka. A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed, DOI )

Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. A head-mounted display-based personal integrated-image monitoring system for transurethral resection of the prostate. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 644-649. ( PubMed, DOI )

Ishioka Junichiro, Kihara Kazunori, Higuchi Saori, Nakayama Takayuki, Takeshita Hideki, Yoshida Soichiro, Nakanishi Yasukazu, Kijima Toshiki, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014.11; 40 (6): 842-845. ( PubMed )

Inoue Masaharu, Koga Fumitaka, Yoshida Soichiro, Tamura Tomoki, Fujii Yasuhisa, Ito Eisaku, Kihara Kazunori. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. International journal of radiation oncology, biology, physics. 2014.10; 90 (2): 303-311. ( PubMed, DOI )

Ishioka Junichiro, Masuda Hitoshi, Kijima Toshiki, Tatokoro Manabu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Yonese Junji, Kageyama Yukio, Noro Akira, Morimoto Shinji, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Kihara Kazunori. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer research. 2014.10; 34 (10): 5683-5688. ( PubMed )

Uchida Yusuke, Yoshida Soichiro, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K. Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. The British journal of radiology. 2014.10; 87 (1042): 20130791. ( PubMed, DOI )

Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education. Wideochir Inne Tech Malo Inwazyjne. 2014.09; 9 (3): 449-452. ( PubMed, DOI )

Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori. Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Japanese journal of clinical oncology. 2014.08; 44 (8): 756-761. ( PubMed, DOI )

Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU international. 2014.08; ( PubMed, DOI )

Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Clinical application of a modern high-definition head-mounted display in sonography. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2014.08; 33 (8): 1499-1504. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Tanaka Hiroshi, Satoh Shiro, Fujii Yasuhisa, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World journal of radiology. 2014.06; 6 (6): 344-354. ( PubMed, DOI )

Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. International urology and nephrology. 2014.03; 46 (3): 555-561. ( PubMed, DOI )

Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. European urology. 2014.01; 65 (1): 186-192. ( PubMed, DOI )

Mollapour Mehdi, Bourboulia Dimitra, Beebe Kristin, Woodford Mark R, Polier Sigrun, Hoang Anthony, Chelluri Raju, Li Yu, Guo Ailan, Lee Min-Jung, Fotooh-Abadi Elham, Khan Sahar, Prince Thomas, Miyajima Naoto, Yoshida Soichiro, Tsutsumi Shinji, Xu Wanping, Panaretou Barry, Stetler-Stevenson William G, Bratslavsky Gennady, Trepel Jane B, Prodromou Chrisostomos, Neckers Len. Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Molecular Cell. 2014.01; 53 (2): 317-329. ( PubMed, DOI )

Kobayashi Shuichiro, Koga Fumitaka, Kajino Kohei, Yoshida Soichiro, Ishii Chikako, Tanaka Hiroshi, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamada Tetsuo, Kihara Kazunori. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. Journal of magnetic resonance imaging : JMRI. 2014.01; 39 (1): 172-178. ( PubMed, DOI )

Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urologia internationalis. 2014; 93 (2): 170-175. ( PubMed, DOI )

Miyajima Naoto, Tsutsumi Shinji, Sourbier Carole, Beebe Kristin, Mollapour Mehdi, Rivas Candy, Yoshida Soichiro, Trepel Jane B, Huang Ying, Tatokoro Manabu, Shinohara Nobuo, Nonomura Katsuya, Neckers Len. The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Research. 2013.12; 73 (23): 7022-7033. ( PubMed, DOI )

Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. Journal of urology. 2013.09; 190 (3): 867-873. ( PubMed, DOI )

Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. Journal of urology. 2013.08; 190 (2): 502-508. ( PubMed, DOI )

Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. European radiology. 2013.08; 23 (8): 2206-2214. ( PubMed, DOI )

Fukushima Hiroshi, Masuda Hitoshi, Yokoyama Minato, Tatokoro Manabu, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Japanese journal of clinical oncology. 2013.07; 43 (7): 740-746. ( PubMed, DOI )

Yoshida Soichiro, Tsutsumi Shinji, Muhlebach Guillaume, Sourbier Carole, Lee Min-Jung, Lee Sunmin, Vartholomaiou Evangelia, Tatokoro Manabu, Beebe Kristin, Miyajima Naoto, Mohney Robert P, Chen Yang, Hasumi Hisashi, Xu Wanping, Fukushima Hiroshi, Nakamura Ken, Koga Fumitaka, Kihara Kazunori, Trepel Jane, Picard Didier, Neckers Leonard. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 2013.04; 110 (17): E1604-E1612. ( PubMed, DOI )

Kijima Toshiki, Koga Fumitaka, Fujii Yasuhisa, Yoshida Soichiro, Tatokoro Manabu, Kihara Kazunori. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 2013; 8 (5): e64615. ( PubMed, DOI )

Tatokoro Manabu, Kihara Kazunori, Masuda Hitoshi, Ito Masaya, Yoshida Soichiro, Kijima Toshiki, Yokoyama Minato, Saito Kazutaka, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC urology. 2013; 13 35. ( PubMed, DOI )

Iwai Aki, Bourboulia Dimitra, Mollapour Mehdi, Jensen-Taubman Sandra, Lee Sunmin, Donnelly Alison C, Yoshida Soichiro, Miyajima Naoto, Tsutsumi Shinji, Smith Armine K, Sun David, Wu Xiaolin, Blagg Brian S, Trepel Jane B, Stetler-Stevenson William G, Neckers Len. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012.10; 11 (19): 3649-3655. ( PubMed, DOI )

Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed, DOI )

Tatokoro Manabu, Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Fujii Yasuhisa, Neckers Len, Kihara Kazunori. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. International journal of cancer. 2012.08; 131 (4): 987-996. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. International journal of radiation oncology, biology, physics. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU international. 2012.03; 109 (6): 860-866. ( PubMed, DOI )

Numao Noboru, Kawakami Satoru, Sakura Mizuaki, Yoshida Soichiro, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU international. 2012.03; 109 (5): 665-671. ( PubMed, DOI )

Tsutsumi Shinji, Mollapour Mehdi, Prodromou Chrisostomos, Lee Chung-Tien, Panaretou Barry, Yoshida Soichiro, Mayer Matthias P, Neckers Leonard M. Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proceedings of the National Academy of Sciences of the United States of America. 2012.02; 109 (8): 2937-2942. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle. 2011.12; 10 (24): 4291-4299. ( PubMed, DOI )

Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. European radiology. 2011.10; 21 (10): 2178-2186. ( PubMed, DOI )

Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR. American journal of roentgenology. 2011.01; 196 (1): 110-116. ( PubMed, DOI )

Koga Fumitaka, Yoshida Soichiro, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. ErbB2 and NFkappaB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One. 2011; 6 (11): e27616. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Kawakami Satoru, Ishii Chikako, Tanaka Hiroshi, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010.02; 75 (2): 387-391. ( PubMed, DOI )

Fukushima Hiroshi, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Yoshida Soichiro, Ratovitski Edward, Trink Barry, Kihara Kazunori. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Research. 2009.12; 69 (24): 9263-9270. ( PubMed, DOI )

Koga Fumitaka, Kihara Kazunori, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Masuda Hitoshi, Kageyama Yukio, Kawakami Satoru. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU international. 2009.07; 104 (2): 189-194. ( PubMed, DOI )

Yokoyama Minato, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed, DOI )

Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Kageyama Yukio, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kobayashi Tsuyoshi, Kihara Kazunori. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed, DOI )

Yoshida Soichiro, Fujii Yasuhisa, Yokoyama Minato, Ishii Chikako, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed, DOI )

Yoshida Soichiro, Saito Kazutaka, Koga Fumitaka, Yokoyama Minato, Kageyama Yukio, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU international. 2008.04; 101 (8): 978-981. ( PubMed, DOI )

Masuda Hitoshi, Kihara Kazunori, Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Chancellor Michael B, de Groat William C, Yoshimura Naoki. Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU international. 2008.03; 101 (6): 775-780. ( PubMed, DOI )

Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2008.02; 15 (2): 140-143. ( PubMed, DOI )

Yoshida Soichiro, Hayashi Tetsuo, Morozumi Makoto, Osada Hisato, Honda Norinari, Yamada Takumi. Three-dimensional assessment of urinary stone on non-contrast helical computed tomography as the predictor of stonestreet formation after extracorporeal shock wave lithotripsy for stones smaller than 20 mm. International journal of urology : official journal of the Japanese Urological Association. 2007.07; 14 (7): 665-667. ( PubMed, DOI )

Yoshida Soichiro, Masuda Hitoshi, Yokoyama Minato, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. International journal of urology : official journal of the Japanese Urological Association. 2007.05; 14 (5): 384-387. ( PubMed, DOI )

Yoshida Soichiro, Hayashi Tetsuo, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi. Discrimination between ureteral stent and stone by non-contrast helical computed tomography in the clinical setting. International journal of urology : official journal of the Japanese Urological Association. 2007.02; 14 (2): 171-173. ( PubMed, DOI )

Yoshida Soichiro, Hayashi Tetsuo, Ikeda Jun, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi. Role of volume and attenuation value histogram of urinary stone on noncontrast helical computed tomography as predictor of fragility by extracorporeal shock wave lithotripsy. Urology. 2006.07; 68 (1): 33-37. ( PubMed, DOI )

Hayashi Tetsuo, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Yamada Takumi. Asthenospermia in hay fever patients improved by stopping treatment with histamine H1 receptor antagonists. Int J Urol. 2006.07; 13 (7): 1028-1030. ( PubMed, DOI )

Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo. C-choline positron emission tomography in bladder cancer: report of four cases. International journal of urology : official journal of the Japanese Urological Association. 2006.06; 13 (6): 829-831. ( PubMed, DOI )

Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi. HtrA2 is up-regulated in the rat testis after experimental cryptorchidism. International journal of urology : official journal of the Japanese Urological Association. 2006.02; 13 (2): 157-164. ( PubMed, DOI )

Yoshida Soichiro, Hayashi Tetsuo, Ishii Nobuyuki, Yoshinaga Atsushi, Ohno Rena, Terao Toshiya, Watanabe Toru, Yamada Takumi, Osada Hisato. Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis. International urology and nephrology. 2006; 38 (3-4): 413-415. ( PubMed, DOI )

Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin. Scandinavian journal of urology and nephrology. 2005; 39 (5): 431-432. ( PubMed, DOI )

Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urologia internationalis. 2005; 74 (3): 214-220. ( PubMed, DOI )

Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Ozawa Takachika. Cystic hamartoma of the renal pelvis. International journal of urology : official journal of the Japanese Urological Association. 2004.08; 11 (8): 653-655. ( PubMed, DOI )

Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Kobayashi Satoshi. Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. International journal of urology : official journal of the Japanese Urological Association. 2004.03; 11 (3): 175-177. ( PubMed )

Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi. Abscess formation in the prevesical space and bilateral thigh muscles secondary to osteomyelitis of the pubis--basis of the anatomy between the prevesical space and femoral sheath. Scandinavian journal of urology and nephrology. 2004; 38 (5): 440-441. ( PubMed, DOI )

Yoshida S, Kimura K, Ikeda M, Fukui K, Tsuchiya J, Nakamura Y, Waseda Y, Tanaka H, Tateishi U, Fujii Y.. Quantitative MRI Parameters Providing the Novel Value in Discriminating Muscle-Invasive Bladder Cancer.. The 39th Annual Congress of the European Association of Urology 2024.04.06

Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後：化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

Ito T, Yoshida S, Taniguchi N, Sugimoto M, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. The utility of mixed reality model projection in ultrasound training for medical students.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Yoshida S, Takahara T, Ishii C, Nakagawa K, Toda K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Matsumoto S, Yoshida S, Yamada I, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Tateishi U, Fujii Y. Utility of diffusion-weighted MRI radiomics features in differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: a multi-institutional study.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Abe Y, Takemura Y, Fujii Y. Relationship between nocturia and whole-body fluid distribution assessed by bioelectrical impedance. The 115th annual meeting of the American Urological Association 2020

Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: A multi-institutional study. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y.. Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.. The 114th annual meeting of the AmericanUrological Association, 2019.05.06 Chicago, USA

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

Yoshida S. AUA/JUA International Affiliate Society Meeting 2019 Theme 1: Bladder cancer, Tri-Modality treatment for MIBC.. 113th annual meeting of the American Urological Association 2019.05.05 Chicago, USA.

Matsuoka Y, Uehara S, Yoshida S, Tanabe K, Tanaka H, Kimura T, Moriyama S,Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?. The 114th　annual meeting of the American Urological Association 2019.05.04 Chicago,USA

Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y.. Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA.

Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.Matsuoka Y., Saito K., Fujii Y. ,. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.. 113th annual meeting of the American　Urological Association 2019.05.04 Chicago, USA

Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

木島敏樹, 森山真吾, 福田翔平, 上原翔, 安田庸輔, 吉田宗一郎横山みなと, 石岡準一郎, 松岡陽, 齋藤一隆, 木原和徳, 藤井靖久.，. 副腎皮質癌の治療成績：再発例に対する集学的治療（化学療法、放射線療法、再発巣切除）の有効性. . 第107回日本泌尿器科学会総会 2019.04.18 名古屋

Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.,Matsuoka Y., Saito K., Fujii Y.. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol. . The 34th Annual Congress of the EuropeanAssociation of Urology 2019.03.18 Barcelona, Spain

Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y. . Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

Fukushima H., Kijima T., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

Kasumi Kaneko, Soichiro Yoshida, Yuki Arita, Kouhei Yamamoto, Toshiki　Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka　Saito, Yasuhisa Fujii. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and　diagnostic utility of diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain.

Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y. . Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y.. Loco-regional radiotherapy targeting oligo-progressive lesions in castration-resistant prostate cancer patients: Intra-pelvic localized progressive lesions are the good targets. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.,Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients withhydronephrosis treated with tetramodality bladder sparing therapyincorporating consolidative partial cystectomy.　. The34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain

Uchida Y., Yoshida S., ShimodaH., TanakaH., SakamotoT., UeharaS., YasudaY.,KijimaT., YokoyamaM., IshiokaJ., MatsuokaY., SaitoK., Fujii Y.. Differentiation of chromophobe renal cell carcinoma and renal oncocytomawith whole-lesion ADC analysis on diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Substratification of intermediate-risk non-muscle-invasive bladder cancer based on the prediction of high-risk recurrence: Impact of bladder neck involvement and positive urine cytology. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

Matsuoka Y, Uehara S, Yoshida S, tanabe K, Tanaka H, KimuraT, Moriyama S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who gains additional benefits from systematic biopsy concurrently performedwith MRI-ultrasound fusion targeted biopsy in the detection of significantprostate cancer?. he 34th Annual Congress of the European Association of Urology, 2019.03.16 Barcelona, Spain

Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.. Clinical outcomes of muscle-invasive bladder cancer patients with. Genitourinary Cancers Symposium 2019.02.15 San　Francisco, USA

木島敏樹、安田庸輔、上原翔、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. 筋層浸潤膀胱癌に対する4者併用膀胱温存療法（TUR＋低用量化学放射線療法＋膀胱部分切除）：Histologic variantを有する症例での検討．. 日本泌尿器腫瘍研究会第4回学術集会 2018.10.20 横浜

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. The role of MRI-targeted biopsy in prediction of adverse pathologicaland oncological outcome after radical prostatectomy. The 114th annual meeting of the American Urological Association 2018.05.20 San Francisco

Yokoyama M, Kawamura N, Uehara S, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy.. The 113rd annual meeting of the American Urological Association 2018.05.19 San Francisco, USA

1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. MRI-based risk assessment for postoperative biochemical recurrenceusing the Prostate Imaging Reporting and Data System (PI-RADS) scoresand capsular contact length. The 114th annual meeting of the American Urological Association 2018.05.18 San Francisco

Junichiro Ishioka*, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Tomo Kimura, Kosei Kudo,Itsuo Kumazawa, Yasuhisa Fujii. Deep learning with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy. 第106回日本泌尿器科学会総会 2018.04.19 京都

木島 敏樹, 吉田 宗一郎, 横山みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久.. 熱ショック因子（Heat shock factor 1: HSF1）阻害によるARスプライスバリアントを標的とした去勢抵抗性前立腺癌に対する新規治療．. 第106回日本泌尿器科学会総会 2018.04.19 京都

吉田　宗一郎. 全身拡散強調画像の歴史と発展. 第77回日本医学放射線学会総会、シンポジウム12 2018.04.15 横浜

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

Yajima S, Yoshida S, Takahara T,Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. The 18th annual meeting of the European Association of Urology 2018.03.19 Copenhagen, Denmark

Yoshida S., Takahara T., Ishii C., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y. 935 METastasis Reporting And Data System for Prostate cancer (MET-RADS-P) score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. The 33th Annual Congress of the European Association of Urology 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.18 Denmark

Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.17 Denmark

Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.16 Denmark

Yuma Waseda, Kazutaka Saito, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography.. AUA Annual Meeting 2017 2017.05.15 Boston

Takayuki Nakayama, Toshiki Kijima, Soichiro Yoshida, Fumitaka Koga, Kazunori Kihara and Yasuhisa Fujii. Zoledronic acid sensitizes castration-resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT1. AUA Annual Meeting 2017 2017.05.15

Inoue M, Fujii Y, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K.. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. AUA Annual Meeting 2017 2017.05.14 Boston

Yuma Waseda, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer.. AUA Annual Meeting 2017 2017.05.13 Boston

井上雅晴,井靖久,藤将也,木島敏樹,田宗一郎,横山みなと,石岡淳一郎,松岡　陽,齋藤一隆,木原和徳. 腎部分切除後の高血圧発症・増悪およびそのリスク因子. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析：筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害：発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical　recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu,　Ito　Masaya,　Kijima　Toshiki,　Yoshida　Soichiro,　Yokoyama　Minato,　Ishioka　Junichiro,　Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

N. Kawamura, K. Saito, M. Inoue, M. Ito, T. Kijima, S. Yoshida,M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Kihara, Y. Fujii. Adherent perinephric fat in Asian patients: predictors, andimpact on perioperative outcomes of partial nephrectomy. 32nd Annual EAU Congress 2017.03.27 London、England

N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction　. 32nd Annual EAU Congress 2017.03.27 London、England

Saito K, Matsuoka Y, Numao N, Hayashi K, Toda K, Ito M, Inoue M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Hemi-gland brachytherapy for localized prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

Matsuoka Y, Saito K, Numao N, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Risk assessment for undertreatment in focal therapy and its applicability to intermediate- and high-risk prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

S. Yoshida, F. Koga, H. Tanaka, H. Fukushima, Y. Nakanishi, M. Yokoyama, J. Ishioka, Y. Matsuoka, N. Numao, K. Saito, Y. Fujii, K. Kihara.. Apparent diffusion coefficient ratio as a potential inter-institutional marker for histological grade of bladder cancer. 24th International Society of Magnetic Resonance in Medicine (ISMRM) 2016.05.12 Singapore

13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 USA

Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 USA

Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 San diego, USA

Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 USA

Yoshida S et al. . Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA,

Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07

Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego, USA

Nakamura Y et al. . High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. 米国泌尿器科学会（annual meeting of the American Urological Association 2016.05.06 San diego, USA

Nakamura Y et al.. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. 米国泌尿器科学会（annual meeting of the American Urological Association 2016.05.06 San diego, USA

Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego

Ishioka J et al.. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego, USA

Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 USA

Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany

Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13

Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.12 Munich, Germany

Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.12 Munich, Germany

Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam

Yoshida S., Tanabe K., Koga F., Inoue M., Kobayashi S., Ishioka J., Tamura T., Sugawara E., Saito K., Akashi T., Fujii Y., Kihara K. Favorable survival outcomes after a chemoradiation-based multimodal approach against muscle-invasive bladder cancer with high Ki-67 expression. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal MRI-targeted biopsy sampling number. The 111th annual meeting of the American Urological Association 2015.05.17

Yoshida S., Fukuda S., Kanda T., Fukui N., Saito K., Fujii Y., Kageyama Y, Kihara K. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA,

Yoshida S., Fukuyo T., Ito M., Tatokoro M., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. Development of new three-dimensional image system for transurethral surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

2.Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. A novel three-dimensional image display system for transurethral surgery. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

8.Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.. Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

5.Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

9.Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival. The 30th Annual Congress of the European Association of Urology 2015.03.21

Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Kazunori Kihara. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. 30th Annual EAU Congress 2015.03.21 Madrid, Spain

10.Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid. The 30th Annual Congress of the European Association of Urology 2015.03.21 Madrid, Spain

Yoshida Soichiro, Koga Fumitaka, Tanaka Hiroshi, Satoh Shiro, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kasutaka, Fujii Yasuhisa, Kihara Kazunori. Diffusion-weighted MRI for assessing the response of muscle-invasive bladder cancer to chemoradiotherapy. (Yoshida Soichiro, Koga Fumitaka, Tanaka Hiroshi, Satoh Shiro, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kasutaka, Fujii Yasuhisa, Kihara Kazunori). The 108th annual meeting of the American Urological Association 2014.05.17 Orlando, USA

Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Inoue Masaharu, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Head-mounted display-based personal integrated-image monitoring system for TURP. (Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Inoue Masaharu, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa). The 29th Annual Congress of the European Association of Urology 2014.04.13 Stockholm, Sweden

Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K.. The ADC value is a prognostic biomarker of upper urinary tract cancer: Potential application to preoperative risk stratification.. The 28th Annual Congress of the European Association of Urology 2013.03.16